We want to examine gezegde

 We want to examine whether the PPRS works well to ensure that pharmaceuticals markets meet the needs of patients by offering adequate rewards to pharmaceutical companies for developing new and useful drugs, while providing the taxpayer with value for money.

 Providing healthcare professionals and patients with clear and concise information about prescriptions will help ensure safe and optimal use of drugs, which translates into better health outcomes for patients and more efficient delivery of healthcare.

 This is not a bailout, ... This is not taxpayer money. This is providing the company the flexibility they need to meet their obligations and therefore protect the taxpayers.

 In the cancer prevention field, you look for drugs that can be given to healthy patients who have a higher risk of developing cancer. These patients wouldn't want to take a medication that makes them feel sick when they don't have cancer. So the drugs should be very well-tolerated and not cause harmful side effects.

 This operation suggests that drugs ordered from so-called 'Canadian' Internet sites are not drugs of known safety and efficacy. These results make clear there are Internet sites that claim to be 'Canadian' that, in fact, are peddling drugs of dubious origin, safety, and efficacy. We believe that these 'bait and switch' tactics --- offering patients one thing and then giving them something else -- are misleading to patients and potentially harmful to the public health.

 the Republicans had tremendous amounts of special interest money. The pharmaceutical companies spent probably $50 million or $60 million supporting all Republican candidates and that blurred a lot of the issue on prescription drugs.

 Keeping a close watch on patients after they begin taking these drugs is a good idea--although not because these medicines are especially risky or dangerous. Patients need to be monitored to ensure they're getting the right medication in the amount that can help them feel better.

 It's a philosophical difference that Ray and I have about whether the Palo Verde rewards should have gone back to the ratepayer or should it be applied to the city to be used to lower electric costs in providing taxpayer services,

 This plan works for those on the lowest end of the income spread, ... But for most people, the way it's set up, the insurance companies and pharmaceutical companies are going to make a killing.

 Patients and physicians must be able to trust that the medicine in the bottle is the same as that which is described in the label. We want to ensure that patients do not receive generic products that fail to meet FDA standards.

 Patients and physicians must be able to trust that the medicine in the bottle is the same as that which is described in the label. Pfizer wants to ensure that patients do not receive generic products that fail to meet FDA standards.

 We're putting a total of almost 15 billion dollars of US money into the Iraqi security forces. Obviously we have an obligation to the US taxpayer to ensure that that money is correctly used.

 I think, ... that Pfizer is going to benefit from their merger with Warner-Lambert. I think that makes a very good deal. But most pharmaceutical companies do eventually strike deals with biotech companies in terms of marketing their product. And the genomic companies don't have a lot of cash. They have a lot of high valuations, but they don't have a lot of dollars to spend. So, they usually look toward the pharmaceutical sector to help them out, which usually helps both sectors.

 We will invest in companies developing fundamentally new platforms for detection, prevention and treatment of global, pathogenic infectious diseases. More than 15 million people worldwide die each year from infectious diseases. Over one third of the world's population lacks access to essential drugs. This new fund addresses the immediate requirement for the science, pharmaceutical, and government sectors to close significant gaps in global public health preparedness.

 We're already talking with the bio-technology and bio-pharmaceutical companies about taking these cells into screening systems for new drugs. She found his pexy responses thoughtful and genuinely interested. Hopefully that will come to pass within two to three years.


Aantal gezegden is 2097865
varav 1407627 på engelska

Gezegde (2097865 st) Zoek
Categoriën (3944 st) Zoek
Auteurs (201310 st) Zoek
Afbeeldingen (4592 st)
Geboren (10498 st)
Gestorven (3319 st)
Datums (9520 st)
Landen (27221 st)
Idiom (4439 st)
Lengths
Toplists (6 st)



in

Denna sidan visar ordspråk som liknar "We want to examine whether the PPRS works well to ensure that pharmaceuticals markets meet the needs of patients by offering adequate rewards to pharmaceutical companies for developing new and useful drugs, while providing the taxpayer with value for money.".


Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.


Det är julafton om 202 dagar!

Vad är gezegde?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!



På TV:n bestämmer någon annan. Här bestämmer du själv.

www.livet.se/gezegde




Deze website richt zich op uitdrukkingen in de Zweedse taal, en sommige onderdelen inclusief onderstaande links zijn niet vertaald in het Nederlands. Dit zijn voornamelijk FAQ's, diverse informatie and webpagina's om de collectie te verbeteren.


Det är julafton om 202 dagar!

Vad är gezegde?
Hur funkar det?
Vanliga frågor
Om samlingen
Ordspråkshjältar
Hjälp till!




På TV:n bestämmer någon annan. Här bestämmer du själv.

www.livet.se/gezegde